Omega Healthcare Investors’ (OHI) Hold Rating Reaffirmed at Stifel Nicolaus

Omega Healthcare Investors (NYSE:OHI)‘s stock had its “hold” rating reissued by equities researchers at Stifel Nicolaus in a research note issued on Wednesday, MarketBeat.com reports. They presently have a $27.00 target price on the real estate investment trust’s stock, down from their prior target price of $29.00. Stifel Nicolaus’ price target would indicate a potential upside of 5.43% from the stock’s current price.

OHI has been the topic of a number of other research reports. TheStreet lowered Omega Healthcare Investors from a “b-” rating to a “c” rating in a research note on Monday, October 30th. Capital One Financial assumed coverage on Omega Healthcare Investors in a research note on Monday, October 23rd. They set an “equal weight” rating and a $34.00 price target on the stock. Vetr lowered Omega Healthcare Investors from a “buy” rating to a “hold” rating and set a $32.96 price target on the stock. in a research note on Monday, October 30th. Zacks Investment Research lowered Omega Healthcare Investors from a “hold” rating to a “sell” rating in a research note on Tuesday, January 2nd. Finally, Hilliard Lyons lowered Omega Healthcare Investors to a “buy” rating in a research note on Wednesday, November 1st. Three research analysts have rated the stock with a sell rating, five have assigned a hold rating and two have assigned a buy rating to the company. Omega Healthcare Investors presently has a consensus rating of “Hold” and a consensus target price of $31.57.

Omega Healthcare Investors (NYSE:OHI) traded down $1.35 during mid-day trading on Wednesday, reaching $25.61. The company’s stock had a trading volume of 7,510,000 shares, compared to its average volume of 2,370,000. The company has a debt-to-equity ratio of 1.18, a quick ratio of 3.40 and a current ratio of 3.40. Omega Healthcare Investors has a twelve month low of $24.90 and a twelve month high of $35.14. The stock has a market capitalization of $5,050.00, a price-to-earnings ratio of 33.70, a price-to-earnings-growth ratio of 2.72 and a beta of 0.41.

Omega Healthcare Investors (NYSE:OHI) last released its earnings results on Tuesday, February 13th. The real estate investment trust reported $0.31 earnings per share for the quarter, missing analysts’ consensus estimates of $0.49 by ($0.18). Omega Healthcare Investors had a return on equity of 3.92% and a net margin of 17.61%. The business had revenue of $221.21 million during the quarter, compared to analysts’ expectations of $219.07 million. equities research analysts forecast that Omega Healthcare Investors will post 3.21 earnings per share for the current fiscal year.

In other news, Director Bernard J. Korman purchased 100,000 shares of the business’s stock in a transaction dated Friday, December 22nd. The shares were purchased at an average price of $26.89 per share, for a total transaction of $2,689,000.00. Following the completion of the purchase, the director now owns 896,895 shares in the company, valued at approximately $24,117,506.55. The purchase was disclosed in a document filed with the SEC, which is available at this link. Company insiders own 1.54% of the company’s stock.

Several institutional investors have recently made changes to their positions in OHI. Parametric Portfolio Associates LLC boosted its position in Omega Healthcare Investors by 21.6% during the second quarter. Parametric Portfolio Associates LLC now owns 226,601 shares of the real estate investment trust’s stock valued at $7,482,000 after purchasing an additional 40,277 shares in the last quarter. Royal Bank of Canada boosted its position in Omega Healthcare Investors by 25.1% during the second quarter. Royal Bank of Canada now owns 187,949 shares of the real estate investment trust’s stock valued at $6,207,000 after purchasing an additional 37,654 shares in the last quarter. Macquarie Group Ltd. boosted its position in Omega Healthcare Investors by 16.0% during the second quarter. Macquarie Group Ltd. now owns 65,255 shares of the real estate investment trust’s stock valued at $2,155,000 after purchasing an additional 9,000 shares in the last quarter. Janus Henderson Group PLC boosted its position in Omega Healthcare Investors by 228.3% during the second quarter. Janus Henderson Group PLC now owns 61,298 shares of the real estate investment trust’s stock valued at $2,024,000 after purchasing an additional 42,629 shares in the last quarter. Finally, State Street Corp boosted its position in Omega Healthcare Investors by 4.3% during the second quarter. State Street Corp now owns 6,278,985 shares of the real estate investment trust’s stock valued at $207,335,000 after purchasing an additional 258,035 shares in the last quarter. Hedge funds and other institutional investors own 67.90% of the company’s stock.

TRADEMARK VIOLATION WARNING: This news story was first published by American Banking News and is the sole property of of American Banking News. If you are reading this news story on another site, it was copied illegally and reposted in violation of U.S. & international copyright and trademark laws. The correct version of this news story can be read at https://www.americanbankingnews.com/2018/02/14/omega-healthcare-investors-ohi-hold-rating-reaffirmed-at-stifel-nicolaus.html.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc is a self-administered real estate investment trust (REIT). The Company maintains a portfolio of long-term healthcare facilities and mortgages on healthcare facilities located in the United States and the United Kingdom. It operates through the segment, which consists of investments in healthcare-related real estate properties.

Analyst Recommendations for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply